Published in Gene Therapy Weekly, March 2nd, 2006
"In vivo, tracheal gland serous cells highly express the CF transmembrane conductance regulator (CFTR) gene. This gene is mutated in the lethal monogenic disease CF," wrote S. Bastonero and colleagues, INSERM U724.
"Clinical trials in which the human CFTR cDNA was delivered to the respiratory epithelia of CF patients have resulted in weak and transient gene expression."
The researchers explained, "As CF is characterized by mucus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-03-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.